As a kid, Elizabeth Holmes spent a lot of time with her uncle.
“I remember his love of crossword puzzles and trying to teach us to play football,” she said, while speaking at TEDMED 2014 in San Francisco. She recalled his love of the beach and how she spent summers and holidays with him.
But one day he was diagnosed with skin cancer, and doctors soon realised the cancer had already spread.
That illness “all of a sudden was brain cancer and in his bones,” she said. “He didn’t live to see his son grow up and I never got to say goodbye.”
Holmes uses what happened to her uncle as a way of explaining why she started Theranos, a company valued at $US9 billion that’s transforming medicine by re-inventing the blood test.
The problem Holmes identified with her uncle’s cancer is that we usually diagnose disease when a person showing symptoms decides to get those symptoms checked out at a doctor. Oftentimes that doctor’s visit happens too late.
With Theranos, Holmes says she wants to offer individuals an easier, faster, cheaper way of getting access to their own health information, allowing them to transform their own behaviour or to get treatment for serious health conditions earlier, giving them more time to get help.
“I believe the individual is the answer to the challenges of healthcare but we can’t engage the individual in changing outcomes unless the individual has access to the information they need to do so,” she said.
At TEDMED and in the past, Holmes has defined access to health information as a “basic human right.”
And the lab tests Theranos provides, in theory at least, should give people much greater access to information — the very information used in 60-80% of clinical decisions, the company says.
Theranos has partnered with Walgreens, so that anyone who needs (or just wants) a blood test can walk into a drug store — and not just during working hours. After submitting to a painless fingerprick, Theranos can run over 70 tests on a tiny sample of blood, checking for anything from blood sugar abnormalities to sexually transmitted infections, all for 50-90% cheaper than Medicare reimbursement rates.
That model has attracted investors and a notable board of directors. For patients, though, making that kind of health information easily accessible has the potential make doctors visits and associated lab tests easier, cheaper, more convenient, and essentially painless. Still, it remains to be seen whether people will fully adopt the approach she envisions, where individuals track their health with the system “almost the way they might use a bathroom scale to watch their weight,” as Roger Parloff describes it in his excellent Fortune profile of Holmes.
If that goal is a success, changing the blood test would really be transforming our whole societal approach towards medicine.
Check out the full TEDMED talk below.
NOW WATCH: Briefing videos
Business Insider Emails & Alerts
Site highlights each day to your inbox.